» Authors » Aaron Schultz

Aaron Schultz

Explore the profile of Aaron Schultz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 1489
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Coughlan G, Rubinstein Z, Klinger H, Lopez K, Hsieh S, Boyle R, et al.
Sci Adv . 2025 Mar; 11(10):eadt1288. PMID: 40043125
Elucidating the downstream impact of exogenous hormones on the aging brain will have far-reaching consequences for understanding why Alzheimer's disease (AD) predominates in women almost twofold over men. We tested...
2.
Klaassen H, Tissot S, Meliani J, Boutry J, Miltiadous A, Biro P, et al.
Proc Biol Sci . 2024 Feb; 291(2016):20232666. PMID: 38351808
Wildlife is increasingly exposed to sublethal transient cancer risk factors, including mutagenic substances, which activates their anti-cancer defences, promotes tumourigenesis, and may negatively impact populations. Little is known about how...
3.
Pang H, Allinson M, Northcott K, Schultz A, Scales P
Water Res . 2023 Aug; 244:120427. PMID: 37567126
The performance of individual reverse osmosis (RO) systems varies significantly with different contaminants of emerging concern (CECs). As such, log reduction values (LRVs) of the concentration of these chemicals cannot...
4.
Lopera F, Marino C, Chandrahas A, OHare M, Villalba-Moreno N, Aguillon D, et al.
Nat Med . 2023 May; 29(5):1243-1252. PMID: 37188781
We characterized the world's second case with ascertained extreme resilience to autosomal dominant Alzheimer's disease (ADAD). Side-by-side comparisons of this male case and the previously reported female case with ADAD...
5.
Young C, Winer J, Younes K, Cody K, Betthauser T, Johnson S, et al.
JAMA Neurol . 2022 Apr; 79(6):592-603. PMID: 35435938
Importance: Characterization of early tau deposition in individuals with preclinical Alzheimer disease (AD) is critical for prevention trials that aim to select individuals at risk for AD and halt the...
6.
Grober E, Papp K, Rentz D, Sperling R, Johnson K, Amariglio R, et al.
Alzheimers Dement (Amst) . 2022 Jan; 13(1):e12224. PMID: 35005192
Introduction: To assess the relationship between memory performance defined by the Stages of Objective Memory Impairment (SOMI) system and the Alzheimer's disease (AD) ATN (amyloid beta [A], pathologic tau [T],...
7.
Papp K, Samaroo A, Chou H, Buckley R, Schneider O, Hsieh S, et al.
Alzheimers Dement (Amst) . 2021 Oct; 13(1):e12243. PMID: 34621977
Introduction: Unsupervised digital cognitive testing is an appealing means to capture subtle cognitive decline in preclinical Alzheimer's disease (AD). Here, we describe development, feasibility, and validity of the Boston Remote...
8.
Goodheart A, Locascio J, Samore W, Collins J, Brickhouse M, Schultz A, et al.
Brain . 2021 Feb; 144(1):266-277. PMID: 33578418
Multiple neuropathological processes can manifest in life as a corticobasal syndrome. We sought to relate retention of the tau-PET tracer 18F-AV-1451 and structural magnetic resonance measures of regional atrophy to...
9.
Boutry J, Dujon A, Gerard A, Tissot S, MacDonald N, Schultz A, et al.
iScience . 2020 Nov; 23(11):101716. PMID: 33241195
Cellular cheating leading to cancers exists in all branches of multicellular life, favoring the evolution of adaptations to avoid or suppress malignant progression, and/or to alleviate its fitness consequences. Ecologists...
10.
Dubbelman M, Jutten R, Tomaszewski Farias S, Amariglio R, Buckley R, Visser P, et al.
Alzheimers Res Ther . 2020 Oct; 12(1):138. PMID: 33121534
Background: Impairment in daily functioning is a clinical hallmark of dementia. Difficulties with "instrumental activities of daily living" (IADL) seem to increase gradually over the course of Alzheimer's disease (AD),...